Rejubella 300mg PDO Filler

$92.00

Rejubella 300mg PDO Filler utilizes patented biodegradable poly-dioxanone microspheres (150mg) in CMC gel (150mg) for dual-action aesthetic correction. Its 10-60μm smooth particles provide immediate volume restoration while stimulating endogenous collagen production. Clinically validated by Osong Advanced Medical Innovation Foundation (Patent 10-2019-0124485), with complete 5-month biodegradation and natural long-term results.

Bundle Your Faves, Boost Your Savings!
Mix-And-Match Quantity​ Get More Discount Final Price
5-154%$88.32
16-306%$86.48
31-Unlimited8%$84.64
Description

Rejubella 300mg PDO Filler

Dual-Action Collagen Remodeling Dermal Filler

Advanced Collagen Remodeling Technology

Rejubella® is an FDA-equivalent Class III medical device utilizing biodegradable PDO microspheres (150mg) suspended in CMC gel (150mg) for volumetric restoration. Clinically proven to deliver immediate volume correction (1 week onset) while stimulating endogenous collagen synthesis (4 weeks). Its spherical particles (10-60μm) and 40-year safety profile ensure minimal inflammatory response, with complete biodegradation within 5 months, leaving exclusively autologous collagen for long-lasting results.

Clinical Superiority vs. Conventional Fillers

Enhanced Safety Profile

5-month full biodegradation versus PCL (1-4 years). Smooth spherical microspheres eliminate granuloma risks associated with PLLA crystalline structures.

Long-Term Efficacy

Natural collagen replacement maintains results beyond carrier degradation, avoiding repetitive supplementation needed with traditional fillers.

Multimodal Indications

Combines volumetric restoration with skin rejuvenation – effective for facial contours, static wrinkles, and skin texture optimization.

Precision Formulation

Biomaterial Engineering

  • Microspheres: 150mg PDO (10-60μm)
  • Carrier: 150mg CMC gel
  • Particle structure: Spherical, smooth-surface

Packaging Configuration

  • Unit capacity: 300mg/vial
  • Formats: 1 vial/box & 5 vials/box
  • Sterile medical device

Patented Innovation

Protected under Korean Patent No. 10-2019-0124485. Biodegradation timeline confirmed by Osong Advanced Medical Innovation Foundation.

Clinical Application Protocol

Reconstitution

Add 5ml sterile water + 1-2ml lidocaine via 18G needle

Suspension

Vigorous shaking until homogeneous mixture achieved

Aspiration

Transfer using 18G needle to syringe

Implantation

Deliver via 26G cannula to mid/deep dermis

Treatment Areas

Facial volumization (temples/cheeks)

Chin contour enhancement

Static wrinkle correction

Skin texture rejuvenation

Medical Usage Notice

Rejubella® is a Class III medical device for licensed practitioners only. Results vary based on individual tissue response and injection technique. All product specifications subject to Korean FDA regulations. Patent No. 10-2019-0124485 protected in South Korea.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Rejubella 300mg PDO Filler”
Review now to get coupon!

Your email address will not be published. Required fields are marked *

You have to be logged in to be able to add photos to your review.